Skip Ribbon Commands
Skip to main content
SharePoint

NIAID Science Forum

Welcome!

This web site hosts the following collaborations:

NexGen-EBA: Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis

This studies the effect of different anti-TB drugs on microbiological, radiographic and immunologic markers in people with TB.

Principal Investigator: Clifton E. Barry III, Ph.D.
ClinicalTrials.gov Identifier: NCT02371681

PREDICT: Using Biomarkers to Predict TB Treament Duration

Tuberculosis (TB) is a bacterial lung infection. Typical treatment using anti-TB drugs lasts about 6 months. Some people with less severe TB might not need to take the drugs that long. Researchers think a PET/CT lung scan along with estimating how much TB is in the lungs might show who will be cured after only 4 months of treatment.

Principal Investigator: Clifton E. Barry III, Ph.D.
ClinicalTrials.gov Identifier: NCT02821832

IBRSP: International Biomedical Research Support Program

The International Biomedical Research Support Program (IBRSP) manages IT services on behalf of research projects operated jointly by the National Institute of Allergy and Infectious Diseases together with its partners worldwide.  IBRSP deploys and maintains networking infrastructure, high performance computing facilities, storage services, communications systems, and collaboration tools for use by the global scientific community, and it provides technical support to scientists, clinicians, faculty, staff, and students at established offices, laboratories, and field research sites.

( Slack Channel | AWS Console )

UAT: User Acceptance Testing

This site exists for training and testing purposes.